NASDAQ: DRMA
Dermata Therapeutics Inc Stock Forecast, Predictions & Price Target

Analyst price target for DRMA

Based on 1 analyst offering 12 month price targets for Dermata Therapeutics Inc

Min Forecast
$3.00+321.35%
Avg Forecast
$3.00+321.35%
Max Forecast
$3.00+321.35%

Should I buy or sell DRMA stock?

Based on 1 analyst offering ratings for Dermata Therapeutics Inc.

Strong Buy
Strong Buy
1 analysts 100%
Buy
0 analysts 0%
Hold
0 analysts 0%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

Be the first to know when Wall Street analysts revise their DRMA stock forecasts and price targets.

DRMA stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2025-05-21

1 of 1

DRMA vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
DRMA$0.71$3.00+321.35%Strong Buy
XBIO$3.01N/AN/A
GLTO$3.35N/AN/A
CMND$0.86N/AN/A
CNSP$0.81N/AN/A

Dermata Therapeutics Stock Forecast FAQ

Is Dermata Therapeutics Stock a good buy in 2025, according to Wall Street analysts?

The consensus among 1 Wall Street analyst covering (NASDAQ: DRMA) stock is to Strong Buy DRMA stock.

Out of 1 analyst, 1 (100%) are recommending DRMA as a Strong Buy, 0 (0%) are recommending DRMA as a Buy, 0 (0%) are recommending DRMA as a Hold, 0 (0%) are recommending DRMA as a Sell, and 0 (0%) are recommending DRMA as a Strong Sell.

If you're new to stock investing, here's how to buy Dermata Therapeutics stock.

What is DRMA's Price Target?

According to 1 Wall Street analyst that have issued a 1 year DRMA price target, the average DRMA price target is $3.00, with the highest DRMA stock price forecast at $3.00 and the lowest DRMA stock price forecast at $3.00.

The Wall Street analyst predicted that Dermata Therapeutics's share price could reach $3.00 by May 21, 2026. The average Dermata Therapeutics stock price prediction forecasts a potential upside of 321.35% from the current DRMA share price of $0.71.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.